GenMark Diagnostics, Inc
GNMK
GNMK was delisted on the 21st of April, 2021.
105 hedge funds and large institutions have $355M invested in GenMark Diagnostics, Inc in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 9 closing their positions.
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
54% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 24
16% more capital invested
Capital invested by funds: $306M → $355M (+$48.7M)
7% more funds holding
Funds holding: 98 → 105 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$4.5M |
| 2 |
BlackRock
New York
|
+$1.65M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.25M |
| 4 |
Morgan Stanley
New York
|
+$1.19M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$4.69M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$3.71M |
| 3 |
JP Morgan Chase
New York
|
-$3.47M |
| 4 |
CC
Casdin Capital
New York
|
-$2.97M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.63M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SSB
101
Sandy Spring Bank
Olney,
Maryland
| $3K | – | – | – |
|
|
SIM
102
Sonora Investment Management
Tucson,
Arizona
| $3K | – | – | – |
|
|
CAC
103
Certified Advisory Corp
Altamonte Springs,
Florida
| $2K | – | – | – |
|
104
SEI Investments
Oaks,
Pennsylvania
| $2K | +$2.37K | +359 | New |
|
|
105
Adage Capital Partners
Boston,
Massachusetts
| – | -$1.63M | -300,000 | Closed |
|
|
FA
106
FDx Advisors
Chicago,
Illinois
| – | -$275K | -50,620 | Closed |
|
107
Dimensional Fund Advisors
Austin,
Texas
| – | -$119K | -21,960 | Closed |
|
|
MWNA
108
Marshall Wace North America
New York
| – | -$79K | -14,544 | Closed |
|
109
Squarepoint
New York
| – | -$76K | -13,943 | Closed |
|
|
CC
110
Cannell & Co
New York
| – | -$54K | -10,000 | Closed |
|
|
EMG
111
ETF Managers Group
Summit,
New Jersey
| – | -$28K | -5,480 | Closed |
|
|
PCM
112
Prelude Capital Management
New York
| – | -$18K | -3,248 | Closed |
|
|
GT
113
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$4K | -1,000 | Closed |
|
114
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$377 | +57 | +1,425% |
|
GNMK Hedge Fund Activity: Q2 2018 in Review
105 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q2 2018, worth a combined $355M — up 16% from $306M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new GNMK positions and 9 closed out — a net gain of 7 holders — while 37 added to existing stakes and 24 trimmed.
The largest buyer was Millennium Management, adding an estimated $4.5M. The largest seller was Putnam Investments, cutting an estimated $4.69M.
- 105 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q2 2018, up from 98 in Q1 2018.
- Funds reported $355M of GenMark Diagnostics, Inc stock for Q2 2018, up 16% quarter-over-quarter.
- 16 funds opened new GenMark Diagnostics, Inc positions in Q2 2018 and 9 closed out, a net change of +7 holders.
- The largest GenMark Diagnostics, Inc buyer in Q2 2018 was Millennium Management, an estimated $4.5M added.
- The largest GenMark Diagnostics, Inc seller in Q2 2018 was Putnam Investments, an estimated $4.69M sold.
Based on aggregated 13F filings for Q2 2018.